5 Steps to Get a Second Opinion from Physicians Affiliated with Memorial Sloan Kettering and Other Top U.S. Cancer Centers Without Leaving Home
- Medebound HEALTH
- Dec 12, 2025
- 11 min read
Updated: 1 day ago
Author: Medical Editor Sue
This service is designed for international patients and families seeking clarity before travel or major treatment decisions.
Table of Contents:
Looking for a second opinion from Memorial Sloan Kettering Cancer Center but unable to travel to New York?
Many international patients searching for an MSK second opinion are surprised to learn that the hospital's formal remote submission program has been paused. Memorial Sloan Kettering Cancer Center (MSKCC), along with MD Anderson Cancer Center, Mayo Clinic, Dana-Farber Cancer Institute, and Massachusetts General Hospital—America's top 5 cancer centers as ranked by U.S. News & World Report—are known worldwide for top cancer experts, advanced treatments, and deep experience with complex cases. For instance, specialists at these institutions treat over 400 distinct cancer types.
However, traveling to U.S. is simply not possible because of health, cost, work, or family constraints. In-person consultations remain available, but international patients who cannot travel often need to explore alternative pathways to obtain expert input from U.S. oncology specialists before making major treatment decisions.
This guide explains:
The current status of MSK second opinions in 2026
Realistic ways to obtain a collaborative second opinion from oncologists affiliated with America's top 5 cancer centers remotely.
How structured remote consultations are typically arranged today
When a collaborative remote opinion is sufficient — and when a hospital visit may be warranted
Why Expert Second Opinions from Leading U.S. Cancer Centers Matter When You Cannot Travel
An expert second opinion from independent specialists with backgrounds at top U.S. cancer centers like Memorial Sloan Kettering, MD Anderson, or Mayo Clinic gives you more than just another set of eyes. It gives you a careful check on your diagnosis, new ideas for treatment, and fewer “what if” questions later.
These leading independent specialists see huge numbers of cancer cases every year, including rare and difficult ones. That kind of experience helps them spot patterns, small details in scans or pathology, or clinical trial options that a smaller center might not see. They can confirm your diagnosis, change your treatment, or even simplify care.
This matters even more if you have stage 3 or 4 cancer, a rare tumor, or several treatment paths that look very different.
Many people seek expert second opinions from independent specialists affiliated with these top U.S. cancer centers, even if they plan to keep treatment close to home, just to feel sure they are doing everything possible.
The hard part is that travel to the United States is not realistic for many patients. Travel budget, health, visas, time off work, or caring for children or parents can all get in the way.
In those cases, a safe and organized remote consultation pathway is not only reasonable but also often the only practical choice.
Important: All consultations are provided by independent U.S.-licensed physicians and are not services of any hospital or cancer center as an institution.
When to Seek an Expert Second Opinion from Top U.S. Doctors
You do not need a specific clinical justification to request a second opinion from U.S. cancer specialists. Wanting independent confirmation is reason enough. That said, several clinical moments make expert review particularly valuable:
Immediately after a new cancer diagnosis, before treatment begins
When the cancer stage has changed or treatment options appear limited
Before major surgery, bone marrow transplant, or high-intensity chemotherapy
When current treatment is not producing the expected response
When you have received significantly different treatment recommendations from different physicians
When you are uncertain whether a proposed treatment plan reflects the most current evidence
Understanding the Current Remote Second Opinion Landscape in 2026
Over the past months, some institutional remote consultation programs at leading U.S. cancer centers, such as MSKCC or MD Anderson, have been adjusted or paused.
However, before committing to international travel, some families prefer to first gain clarity about their diagnosis, treatment options, and whether pursuing evaluation at a U.S. cancer center would be appropriate.
Through Medebound HEALTH, patients can request a physician case review and educational consultation with independent U.S.-licensed physicians, many of whom trained or have experience at leading cancer centers such as MSK, MD Anderson, or Dana-Farber
Medebound HEALTH facilitates a structured collaborative second opinion through a peer-to-peer physician consultation model. We organize medical records, prepare a structured case summary, and coordinate a physician-to-physician educational consultation between your case physician and an independent U.S.-licensed oncology specialist affiliated with a top U.S. cancer center. This service does not replace clinical care or establish a physician-patient relationship.
This approach is most often used when time, health, or geography makes travel impractical, and when international patients want confirmation that a proposed treatment plan has been evaluated through an expert lens before proceeding.
5 Steps to Get a Educational Guidance from America's Top Specialists With Experience at Top Centers — Without Leaving Home
Step 1: Decide What You Want From The Consultation
Before submitting records, clarify your objectives. This focuses the specialist's review and ensures the report addresses your most important questions.
Ask yourself:
Do I want my diagnosis independently confirmed?
Am I choosing between two or more treatment approaches?
Do I want to know whether clinical trials are relevant to my case?
Do I want independent confirmation that my local treatment plan is appropriate?
Write down three to five specific questions, for example:
Is surgery the most appropriate next step, or are there alternatives?
Would you recommend the same chemotherapy regimen?
Are there active clinical trials that apply to my cancer type and stage?
These questions will shape the specialist's written report.
Step 2: Gather the Medical Records U.S. Specialists Will Need
Comprehensive records help oncologists give you a better analysis. Try to collect:
Pathology report from biopsy or surgery
Imaging reports, such as CT, MRI, or PET scans
Lab test results, especially cancer markers
Operation notes, if you already had surgery
Hospital discharge summaries
A brief treatment summary from your current oncologist
For international patients, obtaining records in English where possible will reduce turnaround time. Record collection can feel logistically demanding; Medebound HEALTH's coordination team assists with this process as part of the service.
Step 3: Understand Your Options for Expert U.S. Second Opinion
If you want an expert second opinion from physicians affiliated with leading U.S. cancer centers, there are two main paths:
In-person second opinion at the top U.S. cancer centers. This can offer a full physical exam and direct contact with multidisciplinary teams at Memorial Sloan Kettering, MD Anderson, Mayo Clinic, Dana-Farber, or Massachusetts General Hospital. However, it requires international or domestic travel, time, and sometimes complex visa approvals or insurance coordination.
Collaborative peer-to-peer second opinion through a trusted service, such as Medebound HEALTH. In this path, your records are collected, organized, and securely reviewed by a specialist affiliated with top U.S. cancer centers. You then receive structured educational guidance without needing to travel.
Step 4: Get Educational Guidance from America's Top Specialists With Experience at Top Centers
Here is how it usually works:
Informed Consent. The patient signs informed consent acknowledging the educational and consultative nature of the service. It does not replace the local doctor's clinical assessment.
Record Collection and Case Preparation. Medebound HEALTH collects and organizes medical records, translations (if needed), and prepares a structured case summary.
Case Physician Presentation. A case physician — the patient's local physician or a designated Medebound-affiliated physician, where appropriate — presents the case. The case physician remains the clinical intermediary responsible for patient care.
Specialist Review. The consulting U.S. physician reviews all materials and provides consultative input, including educational insights on the full range of available treatment options.
Live Peer-to-Peer Conference (if applicable). If a live discussion occurs, it is structured as a peer-to-peer consult conference, with the case physician remaining the clinical intermediary and accountability. Participation is facilitated through this structured format.
Written Consultative Output. Written output is formatted as a physician-to-physician consult memo, summarizing educational insights on diagnosis, treatment options, clinical trial eligibility, and other approaches.
Formal Care Pathway. If formal clinical care at a U.S. institution is appropriate, the patient is directed to the hospital's standard intake pathway.
All consultations are provided by independent U.S.-licensed physicians and are not services of any hospital or cancer center as an institution.
Step 5: Prepare for the Feedback and Next Steps After Your Second Opinion
Once your remote U.S. expert second opinion is complete, you can use this report as a tool, not a verdict. Share it with your local oncologist. Ask:
“How is this plan different from what we are doing now?”
“Can we adjust my treatment based on these suggestions?”
Most people searching for a Memorial Sloan Kettering second opinion already have a confirmed diagnosis — and a treatment plan they are unsure about committing to. The fear is not lack of information. It is the fear of making an irreversible decision
Post-consultation support:
Following your remote expert second opinion, we provide ongoing support including treatment plan implementation guidance, medication access assistance, and coordination of onsite visits to U.S. cancer centres if you and your independent physician determine in-person treatment would be beneficial.
Case Study: Advanced Breast Cancer — When U.S. Expert Review Redirects the Entire Treatment Path
The Patient
"Ms. Wang" (pseudonym), a woman diagnosed with advanced breast cancer, had been receiving endocrine therapy at a leading oncology center in China. Unsatisfied with her treatment progress, she sought international consultation with a specific goal in mind: proton therapy in the United States.
Her full medical records, pathology reports, and treatment history were translated and standardized for expert review.
The Clinical Need
Ms. Wang's treating physician recognized that her clinical trajectory — including questions around her hormonal status and the appropriateness of her current endocrine regimen — warranted specialist input beyond what was available locally. Medebound HEALTH facilitated a structured cross-border physician consultation, connecting her domestic team with "Dr. Bennett" (pseudonym), a breast oncologist with a professional appointment at Memorial Sloan Kettering Cancer Center (MSKCC), New York — one of the world's foremost cancer institutions and a designated NCI Comprehensive Cancer Center.
The Collaborative Consultation
Rather than addressing the initial proton therapy request directly, Dr. Bennett conducted a thorough remote case evaluation alongside the domestic care team — surfacing a clinically significant finding that had been overlooked: the possibility of false menopause, which had direct implications for the appropriateness of the patient's existing endocrine regimen and the entire treatment direction.
The Clinical Direction Established
Through this specialist-to-specialist exchange, Dr. Bennett shared a clear, evidence-based treatment framework for the domestic team's consideration:
Endocrine therapy adjustment: Replace the current fulvestrant-based regimen with tamoxifen, better aligned with the patient's hormonal status given suspected false menopause
Combination therapy: Introduce a CDK4/6 inhibitor alongside the adjusted endocrine backbone to enhance treatment efficacy
Genomic evaluation: Pursue the MSK-IMPACT comprehensive genomic profiling panel to identify actionable mutations and inform future decisions
Key clinical guidance: Traveling to the United States for proton therapy was not recommended — the patient's condition is likely sensitive to optimized endocrine therapy and can be effectively managed domestically
The Outcome
What began as a request for proton therapy abroad ended with something more clinically valuable: a precise recalibration of the existing treatment plan, fully achievable at home — sparing the patient an estimated $200,000–$300,000 in unnecessary U.S. treatment costs.
"I'm satisfied with the expert's recommendations and will recommend this consultation service to other patients who need help." — Ms. Wang
Key Takeaway
Not every cross-border physician consultation ends with a referral abroad — and that is precisely the point. In this case, collaborative international expert review redirected a patient away from an unnecessary and costly procedure toward a smarter, targeted strategy accessible at home. The right specialist input doesn't always change where a patient is treated. Sometimes, it simply ensures they are treated right.
Understanding Cancer Second Opinion Options and Investment
In-person second opinion at top 5 U.S. cancer centers:
Round-trip international flights: $1,500-3,000
U.S. accommodation (2-3 weeks): $2,000-4,000
Meals and local transportation: $800-1,500
Visa processing: $200-500
Consultation cost: around $8,000-$30,000 (depends on the hospitals) for consultation only, does not include treatment
Total estimated cost: $12,500–$38,000
Collaborative expert second opinion through Medebound HEALTH:
Comprehensive second opinion (written or video): $2,000-6,000 (varies by complexity)
No travel, lodging, or visa expenses
No physical strain or travel risks
Total cost: $2,000-$6,000
This remote option can offer significant cost savings while providing access to independent physicians with affiliations at America's leading cancer institutions.
Note: Access is not always guaranteed for some specialties, but we will strive to help.
Frequently Asked Questions
Is this a medical second opinion?
This is a structured collaborative second opinion conducted through physician-to-physician consultation. It does not replace clinical care.
Does this create a physician-patient relationship?
No. The service is educational and consultative in nature. Patients acknowledge this in writing through signed informed consent before the process begins.
What happens after I receive my second opinion?
You can share the report with your local oncologist to discuss implementing the recommendations. Medebound HEALTH also provides ongoing support, including treatment plan implementation guidance, medication access assistance, and coordination of onsite visits to U.S. cancer centers if you and your independent physician determine in-person treatment would be beneficial.
Does Medebound HEALTH help arrange in-person visits to U.S. cancer centers?
Yes. After your remote second opinion, if you and your independent physician determine that in-person treatment at a U.S. cancer center would be beneficial, we assist with:
• Scheduling onsite appointments at top U.S. cancer centers
• Visa documentation support
• Accommodation arrangements
• Translation services during your visit
• Treatment coordination
We typically arrange on-site consultations and provide comprehensive support throughout your visit.
What credentials do the independent physicians in your network have?
Our network consists of independent U.S.-licensed, board-certified oncologists who have current professional appointments at or training backgrounds from Memorial Sloan Kettering Cancer Center, MD Anderson Cancer Center, Mayo Clinic, Dana-Farber Cancer Institute, and Johns Hopkins—the top 5 U.S. cancer centers as ranked by U.S. News & World Report. Many are also actively involved in clinical research and treatment development.
How much does a collaborative expert second opinion cost?
Remote expert second opinions through Medebound HEALTH range from $2,000-$6,000 depending on the complexity of your case. This includes a comprehensive record review, a detailed written opinion, and in most cases, a virtual face-to-face consultation. This is significantly less than the total cost of traveling to the U.S. for an in-person consultation, which typically ranges from $12,500-$37,000.
Can U.S. residents use this service?
This service is designed for international patients and families seeking clarity before travel or major treatment decisions.
Are the consultations provided by hospitals?
No. All consultations are provided by independent U.S.-licensed physicians and are not services of any hospital or cancer center as an institution.
Conclusion
An educational guidance from independent physicians with affiliations at leading U.S. cancer centers—including Memorial Sloan Kettering, MD Anderson, Mayo Clinic, Dana-Farber, and Massachusetts General Hospital—can change the course of care.
While in-person consultations at these world-class institutions remain fully available, you don't have to travel if your health condition makes it challenging.
If you feel unsure about your current plan, you do not have to stay stuck in doubt. One small step, such as starting a case review, can move you toward more confidence and a treatment path that feels right for you and your family.
Contact Medebound HEALTH today and discover how we've helped thousands of families access top-tier mental healthcare.
Email: support@medeboundhealth.com
Website: www.medeboundhealth.com
WhatsApp: +1 718 213 8508
Free-toll US Phone Number: +1 917 342 2381
Submit the form: Click HERE we will get back within 4 hours
Instant Chat: Click the chat button at the lower right corner of this page
Disclaimer
We strive to maintain the accuracy and provide regular updates for the treatment information described in this article. However, treatment outcomes may vary between individuals. The information provided here is not intended as a diagnostic or treatment recommendation and should not replace the careful evaluation and advice of your attending physician. The service is independently operated by Medebound HEALTH and is not provided, partnered, or affiliated with any hospital center as an institution.
